8-K: Ambac to Acquire ArmadaCare for $250M

Ambac Financial Group will acquire supplemental health program manager ArmadaCare for $250 million, expanding its specialty insurance platform and targeting 2026 accretion.

Summary

• Ambac Financial Group, Inc. (Ambac) and its wholly owned subsidiary Cirrata VI, LLC (Buyer) entered into a Membership Interest Purchase Agreement to acquire ArmadaCorp Capital, LLC and its subsidiaries (ArmadaCare, LLC and Armada Administrators LLC) from Sirius Acquisitions Holding Company (Seller) and Sirius Re Holdings, Inc. (Seller Parent).
• The purchase price for the acquisition is $250,000,000.
• Ambac expects to finance the transaction using a combination of cash on hand and newly issued debt.
• The transaction is anticipated to close in the fourth quarter of 2025, subject to customary closing conditions and regulatory approvals.
• Ed Walker, CEO of ArmadaCare, will continue to lead the health insurance business with his full management team post-acquisition.

Sentiment

Score: 8

Explanation: The acquisition is strategically significant, expanding Ambac's market presence and product diversification into a non-correlated sector. Management expects it to be accretive to shareholders by 2026 and accelerate EBITDA targets, indicating strong financial benefits. The financing is secured, and key management will remain, suggesting a smooth transition and continued operational strength. While general transaction risks exist, the overall outlook presented is highly positive.

Positives

• Diversifies Ambac's distribution business by expanding into the Accident & Health sector with a non-correlated market, enhancing resilience and growth potential.
• ArmadaCare's differentiated business model, characterized by white-glove service and deep regulatory expertise, drives superior retention and creates a durable competitive advantage.
• Deeply integrated carrier relationships, including a new five-year commitment with SiriusPoint, ensure continued capacity.
• Offers complementary product offerings to Ambac's existing A&H businesses, providing a strong distribution network with direct C-suite access and significant cross-sell opportunities.
• Strengthens Ambac's financial profile, expected to materially accelerate its path toward 2028 EBITDA targets.
• The transaction is expected to be accretive to Ambac shareholders by 2026, delivering clear and measurable value creation.

Negatives

• No explicit negatives regarding the acquisition itself were highlighted in the provided text, beyond general risks inherent in such transactions.

Risks

• The transaction may not close if any event, change, or circumstance gives rise to a right for either party to terminate the Acquisition Agreement.
• Potential for legal proceedings to be instituted against the parties to the Acquisition Agreement.
• Failure to obtain necessary regulatory approvals, or the imposition of conditions by regulators that could adversely affect Ambac or the expected benefits of the Acquisition.
• The Acquisition may be more expensive to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions or changes to business or employee relationships resulting from the completion of the Acquisition.
• Uncertainty regarding the ability of the parties to consummate the Acquisition and the timing of the transaction.
• Forward-looking statements and projections are subject to significant uncertainties and contingencies, and there is no assurance that such projections will actually be realized.
• No assurance that the Buyer will obtain the Senior Secured Credit Facilities within the anticipated timeframe, or at all, as the commitment letter has an expiration date.

Future Outlook

Ambac expects the acquisition to close in the fourth quarter of 2025, be accretive to shareholders by 2026, and materially accelerate its progress towards 2028 EBITDA targets. The company aims to scale its pure-play specialty insurance platform.

Management Comments

• "The addition of ArmadaCare materially accelerates the growth and scale of our distribution platform, strengthens specialty product diversification, and expands relationships with distribution and capacity partners." Claude LeBlanc, Ambac President and Chief Executive Officer.
• "Led by CEO Ed Walker, the ArmadaCare team has a proven track record of building a successful business with exceptional leadership and a clear vision of how to compete and succeed in their niche market. We are pleased to welcome them to the Ambac family as a highly valuable addition to our platform." Claude LeBlanc, Ambac President and Chief Executive Officer.
• "We could not be more excited to join the Ambac family of MGAs. Ambac’s commitment to empowering their MGAs, coupled with our deep relationships with long-term underwriting partners, will fuel the continued growth and future success of our business and further establish our position as a leading health insurance solutions provider." Ed Walker, Chief Executive Officer of ArmadaCare.
• "We are delighted to continue our long-term capacity agreement with Armada and look forward to the team continuing to drive strong underwriting performance for our Accident and Health segment. We wish the team well for an exciting new chapter under the ownership of Ambac." Scott Egan, Chief Executive Officer of SiriusPoint.

Industry Context

This acquisition expands Ambac's presence in the attractive Accident & Health sector, broadening its distribution platform across products and business lines into non-correlated markets. This move is part of Ambac's transformation into a pure-play MGA and specialty insurance platform, strengthening its market position and accelerating its distribution strategy.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry benchmarks, comparable companies, projects, or results.

Management Changes

Corporate Governance

Legal Proceedings

• No material Actions pending or threatened in writing against any of the Acquired Companies or affecting their properties or assets.
• No Actions pending or threatened against the Seller or its Affiliates (including Acquired Companies) questioning the validity of the agreement or the right to enter into transactions.

Related Party Transactions

• All Intercompany Agreements between the Acquired Companies and the Seller or its Affiliates (other than the Acquired Companies) are to be terminated or commuted prior to or concurrently with the Closing.
• Seller and its Affiliates will have no further obligation to provide ancillary or corporate shared services to the Acquired Companies post-closing.
• All intercompany loans, notes, advances, receivables, and payables between Acquired Companies and Seller/Affiliates are to be settled, discharged, offset, paid, or repaid in full prior to or concurrently with the Closing.

Stakeholder Impact

• Shareholders (Ambac): Expected to benefit from the transaction being accretive by 2026 and accelerating EBITDA targets, indicating potential for increased shareholder value.
• Employees (ArmadaCare): Continuing employees will receive base salary/wage rates and target annual bonus opportunities no less favorable than prior to closing for 12 months. Other compensation and benefits will also be no less favorable. Ed Walker and his management team will continue to lead the business.
• Customers (ArmadaCare): The acquisition is expected to strengthen product diversification and expand relationships with distribution and capacity partners, potentially leading to enhanced offerings and service continuity.
• Suppliers/Carriers (ArmadaCare): ArmadaCare will continue its valued partnership with current capacity providers, including a new five-year commitment with SiriusPoint, ensuring stability in relationships.
• Creditors (Ambac): The company is securing $120 million in senior secured credit facilities, which will impact its debt profile.

Next Steps

• Closing of the acquisition, expected in the fourth quarter of 2025, subject to customary closing conditions and regulatory approvals.
• Ambac will host a conference call and online webcast on September 30, 2025, to provide an update on strategic priorities and future direction.
• Negotiation and execution of definitive financing documentation for the Senior Secured Credit Facilities.
• Integration of ArmadaCare into Ambac's platform.
• SiriusPoint and ArmadaCare will enter into a new five-year capacity agreement.

Key Dates

Recommendation

The acquisition of ArmadaCare is a highly strategic move for Ambac, significantly advancing its transformation into a pure-play specialty insurance platform. The transaction is expected to be accretive to shareholders by 2026 and accelerate progress towards 2028 EBITDA targets, indicating strong financial upside. ArmadaCare's differentiated business model, strong retention, and deep carrier relationships (including a new 5-year commitment with SiriusPoint) provide a sustainable competitive advantage and clear revenue synergy opportunities. While general M&A risks exist, the financing is committed, and key management continuity is planned, making this a compelling growth catalyst for Ambac.

Keywords

Ambac Financial Group, ArmadaCare, Acquisition, Specialty Insurance, Program Manager, Accident & Health, MGA, Financial Services, Merger, Debt Financing